Antiretroviral therapy for advanced naïve HIV-infected patients: Current status and comparison of two different management strategies

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue SUPPL. 1, 2007, Pages

  Murphy, Robert L ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Division of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

DRUG EFFICACY; DRUG RESISTANCE; DRUG TOLERABILITY; EDITORIAL; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; HIV; HIV INFECTIONS; HUMANS;

EID: 34548145163     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000286594.11191.91     Document Type: Editorial

References (2)

1. Galvan FH, Bing EG, Bluthenthal RN. Accessing HIV testing and care. J Acquir Immune Defic Syndr 2000;25 (Suppl 2):S151-S156.
2. Centers for Disease Control and Prevention. HIV testing among pregnant women - United States and Canada, 1998-2001. MMWR, 2002;51:1013-1016.